A Lux Research report finds that executives are adapting their strategies and partnering with more sophisticated start-ups to find profits from nanotechnology
With nanotechnology shifting from an emphasis on R&D to a focus on commercialization - with $147 billion worth of products enabled by nanotech sold in 2007 - the strategies of global corporations and start-ups working on nanotechnology have shifted, according to a new report by Lux Research.
"Executives at global corporations are no longer in the dark on nanotechnology," said Jurron Bradley, Ph.D., Senior Analyst at Lux Research. "While some skepticism still exists, they have learned from past flops and have instituted an ‘open innovation' model to minimize risk."
To analyze the strategies of global corporations and nanomaterial specialists, Lux Research conducted a new survey of top executives at 31 leading global corporations active in nanotechnology, and drew on data from over 1,000 primary interviews Lux Research Analysts conduct with technology developers annually. The study concludes that:
Please login or register to see the full article
